| Lauren J Gifford, APRN | |
|
8 Limbo Ln, Amherst, NH 03031-1870 | |
| (603) 673-5885 | |
| (603) 672-7150 |
| Full Name | Lauren J Gifford |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 8 Limbo Ln, Amherst, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366841819 | NPI | - | NPPES |
| 067537-23 | Other | NH | STATE LICENSE |
| 3106858 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 067537-23 (New Hampshire) | Primary |
| Entity Name | Foundation Medical Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162037 PECOS PAC ID: 9436140456 Enrollment ID: O20040519001048 |
News Archive
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their first human clinical trial.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that the first cohort of patients has been dosed in a Phase I clinical trial of ME-344, the Company's lead mitochondrial inhibitor drug candidate, in patients with refractory solid tumors.
Claustrophobia can be a debilitating condition and while there are a variety of therapies and treatments that attempt to limit its effects, there has never been a truly convenient, discreet and portable option for those seeking immediate and impactful relief in the event of an ensuing claustrophobic attack. Now, Healthy Brands LLC is introducing calmspace™, which delivers a proprietary therapeutic formula of 100% natural fragrance extracts that may help manage the anxiety resulting from claustrophobic reactions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren J Gifford, APRN Po Box 3677, Nashua, NH 03061-3677 Ph: (603) 577-7900 | Lauren J Gifford, APRN 8 Limbo Ln, Amherst, NH 03031-1870 Ph: (603) 673-5885 |
News Archive
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their first human clinical trial.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that the first cohort of patients has been dosed in a Phase I clinical trial of ME-344, the Company's lead mitochondrial inhibitor drug candidate, in patients with refractory solid tumors.
Claustrophobia can be a debilitating condition and while there are a variety of therapies and treatments that attempt to limit its effects, there has never been a truly convenient, discreet and portable option for those seeking immediate and impactful relief in the event of an ensuing claustrophobic attack. Now, Healthy Brands LLC is introducing calmspace™, which delivers a proprietary therapeutic formula of 100% natural fragrance extracts that may help manage the anxiety resulting from claustrophobic reactions.
› Verified 8 days ago
Rachel M Glavey, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Overlook Dr Unit B5, Amherst, NH 03031 Phone: 603-400-6733 | |
Sarah Tremblay, APRN-FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 282 Route 101 # Units910, Amherst, NH 03031 Phone: 603-249-8883 Fax: 603-249-1107 | |
Ms. Jennifer Elise Shelsky X, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Limbo Ln, Amherst, NH 03031 Phone: 603-673-5885 Fax: 603-672-7150 | |
Kathleen D. Vandenburg, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Meeting Place Plaza 199 Route 101, Amherst, NH 03031 Phone: 603-249-3000 Fax: 603-249-3000 | |
Mrs. Margaret Anne Buff, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 135 State Route 101a, Amherst, NH 03031 Phone: 603-880-7610 Fax: 603-880-7611 | |
Mrs. Kathryn R Duclos, ARNP, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 282 Route 101 U9/10, Amherst, NH 03031 Phone: 603-249-8883 Fax: 603-249-1107 | |
Wendy L Wright, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Liberty Park Units 9 & 10, 282 Route 101, Amherst, NH 03031 Phone: 603-249-8883 Fax: 603-249-1107 |